一个随机对照试验的更新元分析,比较直接口服抗凝剂与华法林对左心室血栓的分辨率
Joseph Magdy1, Maggie He1, Sacchin Arockiam1
1Yorkshire Heart Centre, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds LS1 3EX, UK.
Journal of clinical medicine
|October 16, 2025
概括
直接口服抗凝剂 (DOAC) 在心肌梗塞后的左心室血栓 (LVT) 解决方面表现出与华法林相当的疗效. 这一元分析表明,DOACs是选择患者的LVT治疗的可行替代方案.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 左心室血栓 (LVT) 是已知的心肌梗塞 (MI) 后的并发症.
- 维生素K对抗剂 (VKA) 是传统的治疗方法,但直接口服抗凝剂 (DOAC) 越来越多地使用.
- 有限的数据存在,比较用于LVT分辨率的DOAC和VKA.
研究的目的:
- 对随机对照试验 (RCT) 进行最新的元分析.
- 为了比较DOAC与VKA在实现LVT分辨率方面的有效性.
- 评估安全结果,包括出血和血栓塞栓事件.
主要方法:
- 系统地搜索RCT的科学数据库,直到2025年5月.
- 主要疗效终点:在3个月内完成LVT解析.
- 使用随机效应模型组合风险比率 (RR) 和95%置信区间 (CI).
主要成果:
- 分析了7个RCT,包括554名患者.
- 在DOACs (86%) 和华法林 (81%) (RR 1.01,95%CI 0.93-1.10,p=0.76) 之间,在3个月后的LVT解析没有显著差异.
- 大型出血和中风/血栓栓塞并发症的复合率相似,尽管CI的范围很广.
结论:
- DOACs在3个月内显示出与华法林相似的有效性,用于LVT解决.
- 这些发现支持考虑DOACs作为选择的LVT患者的VKAs的替代品.
- 需要进一步的大规模试验来确认安全性并比较特定的DOAC.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
Venous Thrombosis III: Interprofessional Care
278
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
278
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
Acute Coronary Syndrome III: Diagnostic Studies
209
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
209
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
311
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
311
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
286
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
286


